Misoprostol and the debate over off-label drug use

BJOG. 2005 Mar;112(3):269-72. doi: 10.1111/j.1471-0528.2004.00490.x.
No abstract available

MeSH terms

  • Abortifacient Agents, Nonsteroidal*
  • Abortion, Induced / methods
  • Africa / epidemiology
  • Contraindications
  • Drug Approval
  • Drug Industry
  • Drug Labeling
  • Evidence-Based Medicine
  • Female
  • Humans
  • Labor, Induced / adverse effects*
  • Maternal Mortality
  • Misoprostol*
  • Oxytocics*
  • Pregnancy

Substances

  • Abortifacient Agents, Nonsteroidal
  • Oxytocics
  • Misoprostol